Cano-Jiménez, Esteban
Romero Ortiz, Ana Dolores
Villar, Ana
Rodríguez-Nieto, María Jesús
Ramon, Alba
Armengol, Silvia
Article History
Received: 1 July 2022
Accepted: 15 August 2022
First Online: 7 September 2022
Declarations
:
: The study was approved by the Ethical Board (EB) of all participant hospitals. The EB of H. Fundación Jiménez Díaz in Madrid, Spain, acted as reference EB. The study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. All patients provided written informed consent prior to their participation.
: Not applicable.
: ECJ received funding for research, presentations and advisories: Roche, Boehringer Ingelheim and Galapagos. ADRO received funding for research, presentations and advisories: Roche, Boehringer Ingelheim. AV received funding for consulting fees from Boehringer Ingelheim and Roche; for talks from Boehringer Ingelheim, GlaxoSmithKline and Roche; and funding for conferences attendance and courses from Boehringer Ingelheim, Chiesi, Novartis, Roche. MJRN received funding for research (data monitoring boards), consulting fees and honoraria for presentations/lectures and for being advisor from Boehringer Ingelheim and Roche. AR and SA are full-time employees of Boehringer Ingelheim España.